Sign in

CIK 0000093314

  • Non-accelerated filer
  • Smaller reporting company

VOLITIONRX LTD

Sign in to watch
Ticker
VNRX
Exchange
NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911949078
Phone
+1 512-774-8930
Business address
1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
Former names
VOLITIONRX LTD, STANDARD CAPITAL CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-01 Rootsaert Rodney Gerard Secretary Grant or award +10,190 147,763
2025-06-01 Rootsaert Rodney Gerard Secretary Shares withheld for taxes −6,408 $0.50 $3K 141,355
2025-06-01 Forterre Gael Chief Commercial Officer Grant or award +6,690 165,696
2025-06-01 Forterre Gael Chief Commercial Officer Shares withheld for taxes −4,234 $0.50 $2K 161,462
2025-06-01 Retter Andrew Chief Medical Officer Grant or award +13,069 146,773
2025-06-01 Retter Andrew Chief Medical Officer Shares withheld for taxes −4,598 $0.50 $2K 142,175
2025-06-01 Hughes Terig Chief Financial Officer Grant or award +17,406 407,627

Page 6 of 6 · 107 trades